keyword
MENU ▼
Read by QxMD icon Read
search

Congenital malaria and treatment

keyword
https://www.readbyqxmd.com/read/27879554/measles-and-rubella-seroprevalence-among-hiv-infected-and-uninfected-zambian-youth
#1
Catherine G Sutcliffe, Kelly Searle, Hellen K Matakala, Dip Biomed, Michelle Greenman, Kaitlin Rainwater-Lovett, Philip E Thuma, William J Moss
BACKGROUND: Measles and congenital rubella syndrome remain significant causes of morbidity and mortality despite available vaccines. HIV-infected youth may be at increased risk of measles because of greater waning immunity following vaccination. At a population level, they constitute a potentially large pool of susceptibles to measles and rubella. More data among HIV-infected youth in sub-Saharan Africa are needed to guide vaccination policy and control strategies. METHODS: This cross-sectional study was nested within two ongoing studies of malaria and HIV in Zambia...
November 22, 2016: Pediatric Infectious Disease Journal
https://www.readbyqxmd.com/read/27824884/the-safety-of-artemisinin-derivatives-for-the-treatment-of-malaria-in-the-2nd-or-3rd-trimester-of-pregnancy-a-systematic-review-and-meta-analysis
#2
Stephanie D Kovacs, Anna Maria van Eijk, Esperanca Sevene, Stephanie Dellicour, Noel S Weiss, Scott Emerson, Richard Steketee, Feiko O Ter Kuile, Andy Stergachis
Given the high morbidity for mother and fetus associated with malaria in pregnancy, safe and efficacious drugs are needed for treatment. Artemisinin derivatives are the most effective antimalarials, but are associated with teratogenic and embryotoxic effects in animal models when used in early pregnancy. However, several organ systems are still under development later in pregnancy. We conducted a systematic review and meta-analysis of the occurrence of adverse pregnancy outcomes among women treated with artemisinins monotherapy or as artemisinin-based combination therapy during the 2nd or 3rd trimesters relative to pregnant women who received non-artemisinin antimalarials or none at all...
2016: PloS One
https://www.readbyqxmd.com/read/27774886/the-clinico-hematological-features-and-management-outcome-in-neonatal-malaria-a-nine-years-analysis-from-north-india
#3
Kriti Mohan
BACKGROUND: Malaria is an important cause of death and illness in children worldwide. Most cases of neonatal malaria are misdiagnosed because of the lack of specific symptoms and a general lack of awareness. Nothing much is known in literature about the haematological changes during malaria infection and outcome of disease in neonates. Neonatal malaria is an underdiagnosed entity. So this hospital based observational study aims to assess diagnostic features of neonatal malaria. METHODS: From August 2004 to August 2013, information of all slide positive for malaria cases aged 0 to 28 days admitted to our pediatric hospital was collected and analysed...
October 20, 2016: Infectious Disorders Drug Targets
https://www.readbyqxmd.com/read/27651968/congenital-malaria-due-to-plasmodium-vivax-infection-in-a-neonate
#4
Ravi Bhatia, Dinesh Rajwaniya, Priti Agrawal
Although malaria is endemic in India, congenital malaria is not very common. Congenital malaria is a very rare condition in both endemic and nonendemic areas. We report a case of congenital malaria in a six-day-old neonate with fever and splenomegaly. The diagnosis was picked up accidentally on a peripheral smear examination. Congenital malaria should be kept as differential diagnosis of neonatal sepsis. Timely detection of this condition could lead to early diagnosis and treatment, thereby preventing neonatal mortality...
2016: Case Reports in Pediatrics
https://www.readbyqxmd.com/read/27326859/efficacy-and-safety-of-azithromycin-chloroquine-versus-sulfadoxine-pyrimethamine-for-intermittent-preventive-treatment-of-plasmodium-falciparum-malaria-infection-in-pregnant-women-in-africa-an-open-label-randomized-trial
#5
Joshua Kimani, Kamija Phiri, Steve Kamiza, Stephan Duparc, Ayman Ayoub, Ricardo Rojo, Jeffery Robbins, Russell Orrico, Pol Vandenbroucke
BACKGROUND: The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) in African regions with moderate to high malaria transmission. However, growing resistance to SP threatens the effectiveness of IPTp-SP, and alternative drugs are needed. This study tested the efficacy, tolerability, and safety of a fixed-dose combination azithromycin-chloroquine (AZCQ; 250 mg AZ/155 mg CQ base) for IPTp relative to IPTp-SP. METHODS AND FINDINGS: A randomized, Phase 3, open-label, multi-center study was conducted in sub-Saharan Africa (Benin, Kenya, Malawi, Tanzania, and Uganda) between October 2010 and November 2013...
2016: PloS One
https://www.readbyqxmd.com/read/27078816/prevention-and-treatment-of-mother-to-child-transmission-of-syphilis
#6
Serena Braccio, Mike Sharland, Shamez N Ladhani
PURPOSE OF REVIEW: Athough more than 90% of syphilis cases are diagnosed in developing countries, syphilis rates in industrialized countries have been increasing since the 1980s. Untreated syphilis in pregnancy is associated with high rates of adverse pregnancy outcomes, including fetal loss, premature birth, congenital syphilis, and neonatal death. We reviewed the recent literature on adverse pregnancy outcomes associated with untreated syphilis and the benefits of early and effective treatment...
June 2016: Current Opinion in Infectious Diseases
https://www.readbyqxmd.com/read/26938139/malaria-surveillance-united-states-2013
#7
Karen A Cullen, Kimberly E Mace, Paul M Arguin
PROBLEM/CONDITION: Malaria in humans is caused by intraerythrocytic protozoa of the genus Plasmodium. These parasites are transmitted by the bite of an infective female Anopheles mosquito. The majority of malaria infections in the United States occur among persons who have traveled to regions with ongoing malaria transmission. However, malaria is also occasionally acquired by persons who have not traveled out of the country through exposure to infected blood products, congenital transmission, laboratory exposure, or local mosquitoborne transmission...
March 4, 2016: MMWR. Surveillance Summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries
https://www.readbyqxmd.com/read/26869377/safety-of-artemisinins-in-first-trimester-of-prospectively-followed-pregnancies-an-observational-study
#8
Kerryn A Moore, Julie A Simpson, Moo Kho Paw, MuPawJay Pimanpanarak, Jacher Wiladphaingern, Marcus J Rijken, Podjanee Jittamala, Nicholas J White, Freya J I Fowkes, François Nosten, Rose McGready
BACKGROUND: Artemisinins, the most effective antimalarials available, are not recommended for falciparum malaria during the first trimester of pregnancy because of safety concerns. Therefore, quinine is used despite its poor effectiveness. Assessing artemisinin safety requires weighing the risks of malaria and its treatment. We aimed to assess the effect of first-trimester malaria and artemisinin treatment on miscarriage and major congenital malformations. METHODS: In this observational study, we assessed data from antenatal clinics on the Thai-Myanmar border between Jan 1, 1994, and Dec 31, 2013...
May 2016: Lancet Infectious Diseases
https://www.readbyqxmd.com/read/26788543/artemisinin-based-combination-therapy-versus-quinine-or-other-combinations-for-treatment-of-uncomplicated-plasmodium-falciparum-malaria-in-the-second-and-third-trimester-of-pregnancy-a-systematic-review-and-meta-analysis
#9
REVIEW
Renée J Burger, Anna M van Eijk, Milena Bussink, Jenny Hill, Feiko O Ter Kuile
The World Health Organization recommends artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated falciparum malaria in the second and third trimesters of pregnancy. We conducted a meta-analysis to compare efficacy, safety and tolerability of ACTs versus quinine and other non-ACT antimalarials. The median PCR-adjusted failure rate by days 28 to 63 in the non-ACT group was 6 (range 0-37) per 100 women, lower in the ACT group overall (pooled risk ratio [PRR] random effects, 0.41; 95% confidence interval [CI], 0...
January 2016: Open Forum Infectious Diseases
https://www.readbyqxmd.com/read/26767277/-a-case-of-neonatal-congenital-malaria-accompanied-with-severe-thrombocytopenia
#10
Kang-ming Lin, Hai-piao Yu, Gui-ji Lu, Jun Li, Ya-ming Huang, Wei-wei Zhang, Yi-chao Yang
This article reports the process of diagnosis and treatment of one case of neonatal congenital malaria accompanied with severe thrombocytopenia.
August 2015: Zhongguo Xue Xi Chong Bing Fang Zhi za Zhi, Chinese Journal of Schistosomiasis Control
https://www.readbyqxmd.com/read/26721050/congenital-malaria
#11
Sajid Ali Shah, Zeeshan Ahmed, Munir Akmal Lodhi, Nazir Ahmed Malik
Neonates with congenital malaria may present with non-specific signs and symptoms which may be mistaken for neonatal sepsis and inborn error of metabolism resulting in delay of diagnosis.and significant mortality and morbidity. Here we present a unique case of 25 days old premature female baby who was diagnosed to have mixed malarial infection. Despite standard treatment the patient was not responding well and was also diagnosed to have congenital adrenal hyperplasia.
July 2015: Journal of Ayub Medical College, Abbottabad: JAMC
https://www.readbyqxmd.com/read/26394787/vp-shunt-dysfunction-caused-by-malaria-cns-infection
#12
Michael Karl Fehrenbach, Matthias Bernhard, Manuela Siekmeyer, Norman Lippmann, Wieland Kiess, Ulf Nestler, Jürgen Meixensberger, Matthias Preuss
INTRODUCTION: Malaria is a widespread mosquito-borne infectious disease with over 300 million cases and roughly 900 thousand deaths in 2013. Cerebral involvement of malaria causes 50 % of all infection-associated deaths, especially in children below the age of 5 years. Hydrocephalus is a medical condition with abnormal accumulation of cerebrospinal fluid in physiological cavities and ventricles. Standard treatment is the implantation of a cerebrospinal fluid shunt device. A common problem associated with shunt treatment especially in pediatric patients is infection and consecutive shunt dysfunction caused by bacteriae or high protein levels clogging the valve...
April 2016: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://www.readbyqxmd.com/read/26338383/-congenital-malaria-in-a-hospital-in-iquitos-peru
#13
Hermann Silva, Bernaldo Laulate, Carlos Coral
OBJECTIVES: To determine the frequency and clinical features of newborns with congenital malaria in the Hospital de Apoyo of Iquitos in the Peruvian Amazon. MATERIALS AND METHODS: Descriptive, prospective and cross-sectional study. From January 2011 to December 2013, 14.017 newborns and their mothers were studied, of whom 52 carriers of gestational malaria were selected while their infants were hospitalized in the Neonatology Unit, and underwent clinical assessment and laboratory studies...
April 2015: Revista Peruana de Medicina Experimental y Salud Pública
https://www.readbyqxmd.com/read/26198451/daily-oral-iron-supplementation-during-pregnancy
#14
REVIEW
Juan Pablo Peña-Rosas, Luz Maria De-Regil, Maria N Garcia-Casal, Therese Dowswell
BACKGROUND: Iron and folic acid supplementation has been the preferred intervention to improve iron stores and prevent anaemia among pregnant women, and it is thought to improve other maternal and birth outcomes. OBJECTIVES: To assess the effects of daily oral iron supplements for pregnant women, either alone or in conjunction with folic acid, or with other vitamins and minerals as a public health intervention in antenatal care. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (10 January 2015)...
July 22, 2015: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/26169783/treatment-policy-change-to-dihydroartemisinin-piperaquine-contributes-to-the-reduction-of-adverse-maternal-and-pregnancy-outcomes
#15
Jeanne Rini Poespoprodjo, Wendelina Fobia, Enny Kenangalem, Daniel A Lampah, Paulus Sugiarto, Emiliana Tjitra, Nicholas M Anstey, Richard N Price
BACKGROUND: In Papua, Indonesia, maternal malaria is prevalent, multidrug resistant and associated with adverse outcomes for mother and baby. In March 2006, anti-malarial policy was revised for the second and third trimester of pregnancy to dihydroartemisinin-piperaquine (DHP) for all species of malaria. This study presents the temporal analysis of adverse outcomes in pregnancy and early life following this policy change. METHODS: From April 2004 to May 2010, a standardized questionnaire was used to collect information from all pregnant women admitted to the maternity ward...
July 15, 2015: Malaria Journal
https://www.readbyqxmd.com/read/26064034/congenital-malaria-in-a-neonate-case-report-with-a-comprehensive-review-on-differential-diagnosis-treatment-and-prevention-in-indian-perspective
#16
Preeti Rai, Kaushik Majumdar, Sunita Sharma, Richa Chauhan, Jagdish Chandra
Although malaria in pregnancy, lactation and congenital malaria can be a disease burden in the endemic zones of Africa and Indian sub-continent, it is still epidemiologically less investigated in India. As it may lead to considerable maternal and perinatal morbidity and mortality, awareness and timely intervention is necessary for desirable outcome and prevention of the condition. Very few reports of congenital malaria are available in the literature from an endemic country like India. Herein we describe a case of congenital malaria from north India in a 21-day neonate...
June 2015: Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology
https://www.readbyqxmd.com/read/25556421/treating-severe-malaria-in-pregnancy-a-review-of-the-evidence
#17
REVIEW
Stephanie D Kovacs, Marcus J Rijken, Andy Stergachis
Severe malaria in pregnancy is a large contributor to maternal morbidity and mortality. Intravenous quinine has traditionally been the treatment drug of choice for severe malaria in pregnancy. However, recent randomized clinical trials (RCTs) indicate that intravenous artesunate is more efficacious for treating severe malaria, resulting in changes to the World Health Organization (WHO) treatment guidelines. Artemisinins, including artesunate, are embryo-lethal in animal studies and there is limited experience with their use in the first trimester...
February 2015: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
https://www.readbyqxmd.com/read/25506464/mother-to-children-plasmodium-falciparum-asymptomatic-malaria-transmission-at-saint-camille-medical-centre-in-ouagadougou-burkina-faso
#18
Zoenabo Douamba, Nangnéré Ginette Laure Dao, Théodora Mahoukédé Zohoncon, Cyrille Bisseye, Tegwindé Rebeca Compaoré, Jacques Gilbert Kafando, Bavouma Charles Sombie, Djeneba Ouermi, Florencia W Djigma, Paul Ouedraogo, Nadine Ghilat, Virginio Pietra, Vittorio Colizzi, Jacques Simpore
Background. Malaria's prevalence during pregnancy varies widely in parts of sub-Saharan Africa, including Burkina Faso. The objective of this study was to evaluate the incidence of mother-to-child malaria transmission during childbirth at St. Camille Medical Centre in the city of Ouagadougou. Methods. Two hundred and thirty-eight (238) women and their newborns were included in the study. Women consenting to participate in this study responded to a questionnaire that identified their demographic characteristics...
2014: Malaria Research and Treatment
https://www.readbyqxmd.com/read/25474160/malaria-surveillance-united-states-2012
#19
Karen A Cullen, Paul M Arguin
PROBLEM/CONDITION: Malaria in humans is caused by intraerythrocytic protozoa of the genus Plasmodium. These parasites are transmitted by the bite of an infective female Anopheles mosquito. The majority of malaria infections in the United States occur among persons who have traveled to regions with ongoing malaria transmission. However, malaria is also occasionally acquired by persons who have not traveled out of the country, through exposure to infected blood products, congenital transmission, laboratory exposure, or local mosquitoborne transmission...
December 5, 2014: MMWR. Surveillance Summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries
https://www.readbyqxmd.com/read/25201565/our-paper-20-years-later-inhaled-nitric-oxide-for-the-acute-respiratory-distress-syndrome-discovery-current-understanding-and-focussed-targets-of-future-applications
#20
R Rossaint, K Lewandowski, W M Zapol
INTRODUCTION: More than 20 years have passed since we reported our results of treating patients with the acute respiratory distress syndrome (ARDS) with inhaled nitric oxide (iNO). The main finding was that iNO alleviated pulmonary hypertension (PH) by selective vasodilation of pulmonary vessels in ventilated lung areas. This, in turn, improved arterial oxygenation. METHODS: We now set out to review the time span between the discovery of NO in 1987 and today in order to identify and describe interesting areas of research and clinical practice surrounding the application of iNO...
November 2014: Intensive Care Medicine
keyword
keyword
11140
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"